Table 1 (abstract P163). See text for description
From: Proceedings of the 28th European Paediatric Rheumatology Congress (PReS 2022)
Parameter | Our study (n=38) 2022 | Surendran et al (n=20) 2018 | Roderick et al (n=41) 2016 | Chandrika et al (n= 131) 2018 | German NPRD (n=774) 2020 |
|---|---|---|---|---|---|
Median age of onset of symptom in years | 7.3 | 10.25 | 9 | 9.5 | 11.1 |
Median age of Diagnosis in years. | 8.86 | 11.75 | 11 | 10.7 | NA |
Time to diagnosis in months | 12 | 17.75 | 15 | 12 | 8.4 |
Female | 26.4% | 25% | 75.6% | 71.8% | 62.8% |
Median ESR: | 44.5 | 43 | 27 | NA | 18.7 |
Multifocal | 86.84% | NA | 76% | 83.2% | 63% |
Total no of Bone lesions by WB- MRI | 169 | 100 | 162 | 405 | NA |
Tibial/ Fibula lesions | 26+ 14.8 % | 10 % | 25+ 5 % | NA | 120 + 29 cases |
Mean duration of follow up in months | 27.63 | 11.5 | NA | NA | 12 |